Cargando…

Filgrastim (r-metHuG-CSF) in clinical practice. Basic and clinical oncology series/5

Detalles Bibliográficos
Autor principal:	Crowther, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033349/

Ejemplares similares

Use of Filgrastim (r-metHuG-CSF) in Human Immunodeficiency Virus Infection
por: Hemmige, Vagish, et al.
Publicado: (2011)

Long-term safety of filgrastim (rhG-CSF) administration
por: Confer, Dennis L, et al.
Publicado: (2007)

Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients
por: Johannesen, Siw, et al.
Publicado: (2018)

Differential role of r-met-hu G-CSF on male reproductive function and development in prepubertal domestic mammals
por: Aponte, Pedro M., et al.
Publicado: (2019)

Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size
por: Kiafar, Farhad, et al.
Publicado: (2016)

Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors
por: Farhan, Roiya, et al.
Publicado: (2017)

‘CLINICAL ONCOLOGY – BASIC PRINCIPLES AND PRACTICE’, 4TH EDITION
Publicado: (2011)

Induction of T-cell mitogenic unresponsiveness by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)
por: Rutella, S, et al.
Publicado: (2000)

Controversies in Oncology
por: Crowther, D.
Publicado: (1982)

Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
por: Sörgel, Fritz, et al.
Publicado: (2015)

FIV-infected cats respond to short-term rHuG-CSF treatment which results in anti-G-CSF neutralizing antibody production that inactivates drug activity
por: Phillips, K., et al.
Publicado: (2005)

Filgrastim, fibrinolysis, and neovascularization
por: Eton, Darwin, et al.
Publicado: (2022)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Innovator Filgrastim versus Generic Filgrastim in Hematopoietic Stem Cell Transplantation Mobilization
por: Husian, Sadik, et al.
Publicado: (2021)

Medical Oncology: An Advanced Course
por: Crowther, D.
Publicado: (1981)

Cancer—Principles and Practice of Oncology. V
por: Crowther, D.
Publicado: (1982)

The Basic Science of Oncology. 2nd Edition
por: Twentyman, P.R.
Publicado: (1993)

Basic clinical radiobiology
por: Williams, M. V.
Publicado: (1994)

CLINICAL ONCOLOGY
Publicado: (1978)

Clinical Oncology
por: Barley, V. L.
Publicado: (1991)

Clinical Oncology
Publicado: (1992)

Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing Chemotherapy
por: Schwartzberg, Lee S., et al.
Publicado: (2018)

Medical Oncology: Medical Aspects of Malignant Disease
por: Crowther, D.
Publicado: (1975)

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)
por: Salamone, Paolina, et al.
Publicado: (2020)

The Safety Profile of Filgrastim and Pegfilgrastim
por: Neumann, Theresa A., et al.
Publicado: (2011)

The HuMet Repository: Watching human metabolism at work
por: Weinisch, Patrick, et al.
Publicado: (2023)

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer
por: Repp, R, et al.
Publicado: (2003)

Greenspan’s Basic and Clinical Endocrinology
por: Jayakumar, Asha
Publicado: (2012)

Textbook of Basic and Clinical Orthopaedics
por: Rastogi, Shishir
Publicado: (2012)

Clinical Gynaecologic Oncology
por: Hunter, R.
Publicado: (1981)

Presently available biosimilars in hematology-oncology: G-CSF
por: Gascon, Pere
Publicado: (2012)

Interaction of RNA-binding protein HuR and miR-466i regulates GM-CSF expression
por: Chen, Jing, et al.
Publicado: (2017)

Tumours—Basic Principles and Clinical Aspects
por: Bush, H.
Publicado: (1979)

Clinical Pharmacology—Basic Principles in Therapeutics
Publicado: (1973)

Biosimilars in the management of neutropenia: focus on filgrastim
por: Caselli, Désirée, et al.
Publicado: (2016)

Treatment of natalizumab‐associated PML with filgrastim
por: Stefoski, Dusan, et al.
Publicado: (2019)

Filgrastim associations with CAR T‐cell therapy
por: Gaut, Daria, et al.
Publicado: (2020)

Atlas of Clinical PET in Oncology
por: Price, P
Publicado: (2000)

Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial
por: Waller, Cornelius F., et al.
Publicado: (2010)

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia
por: Sevinç, Alper, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ksjsm2f5rjhpbbtvaoc3vme1m